Quarterly Result10 Nov 2025, 01:39 pm
Epigral Ltd Reports Q2FY26 Revenue of ₹ 589 Crore, Despite Lower Sales Volume and Realization Drop
AI Summary
Epigral Limited, a leading integrated chemical manufacturer in India, announced its financial results for the quarter ended September 30, 2025. The company posted a revenue of ₹ 589 Crore, down by 4% compared to Q2FY25. The decline in revenue was attributed to lower sales volume and a drop in realization of certain products due to an extended monsoon season. Plant utilization stood at 75% for H1FY26, with expectations of improvement in H2FY26 as the monsoon season ends and maintenance work at the plant is completed. Epigral's capacity expansion projects are moving as per schedule and are expected to drive growth from FY2027 onwards.
Key Highlights
- Plant utilization stood at 78% vs 73% in the previous quarter
- Sales volume grew by 2% compared to the previous quarter QoQ
- Revenue dropped by 4% to ₹ 589 Cr on account of drop in realizations in few of the products
- EBITDA margin stood at 23% vs 27% in QIFY26 due to drop in realizations and lower utilization
- PAT stood at ₹ 51 Cr, down from ₹ 81 Cr in Q2FY25